Buchumschlag

Long-term neurocognitive function after whole-brain radiotherapy in patients with melanoma brain metastases in the era of immunotherapy

Whole-brain radiotherapy (WBRT) used to be standard of care for patients suffering from melanoma brain metastases (MBM) and may still be applicable in selected cases. Deterioration of neurocognitive function (NCF) is commonly seen during and after WBRT. Knowledge on long-term effects in melanoma pat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Salzmann, Martin (Verfasst von) , Hess, Klaus (Verfasst von) , Uzun-Lang, Kristin (Verfasst von) , Enk, Alexander (Verfasst von) , Jordan, Berit (Verfasst von) , Hassel, Jessica C. (Verfasst von)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: October 2022
In: Strahlentherapie und Onkologie
Year: 2022, Jahrgang: 198, Heft: 10, Pages: 884-891
ISSN:1439-099X
DOI:10.1007/s00066-022-01950-1
Online-Zugang:Resolving-System, kostenfrei, Volltext: https://doi.org/10.1007/s00066-022-01950-1
Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s00066-022-01950-1
Volltext
Verfasserangaben:Martin Salzmann, Klaus Hess, Kristin Lang, Alexander H. Enk, Berit Jordan, Jessica C. Hassel
Beschreibung
Zusammenfassung:Whole-brain radiotherapy (WBRT) used to be standard of care for patients suffering from melanoma brain metastases (MBM) and may still be applicable in selected cases. Deterioration of neurocognitive function (NCF) is commonly seen during and after WBRT. Knowledge on long-term effects in melanoma patients is limited due to short survival rates. With the introduction of immune checkpoint inhibitors, patients may experience ongoing disease control, emphasizing the need for paying more attention to potential long-term adverse effects.
Beschreibung:Gesehen am 17.11.2022
Beschreibung:Online Resource
ISSN:1439-099X
DOI:10.1007/s00066-022-01950-1

Ähnliche Einträge